<VariationArchive VariationID="811286" VariationName="NM_007129.5(ZIC2):c.1317del (p.Leu440fs)" VariationType="Deletion" Accession="VCV000811286" Version="9" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-28" DateCreated="2020-02-10" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="799754" VariationID="811286">
      <GeneList>
        <Gene Symbol="ZIC2" FullName="Zic family member 2" GeneID="7546" HGNC_ID="HGNC:12873" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>13q32.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="99981784" stop="99986765" display_start="99981784" display_stop="99986765" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="100634025" stop="100639018" display_start="100634025" display_stop="100639018" Strand="+" />
          </Location>
          <OMIM>603073</OMIM>
          <Haploinsufficiency last_evaluated="2022-08-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ZIC2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-08-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ZIC2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_007129.5(ZIC2):c.1317del (p.Leu440fs)</Name>
      <CanonicalSPDI>NC_000013.11:99985396:GGGG:GGG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>13q32.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="99985397" stop="99985397" display_start="99985397" display_stop="99985397" variantLength="1" positionVCF="99985396" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="100637651" stop="100637651" display_start="100637651" display_stop="100637651" variantLength="1" positionVCF="100637650" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>L440fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.11" sequenceAccession="NC_000013" sequenceVersion="11" change="g.99985400del" Assembly="GRCh38">
            <Expression>NC_000013.11:g.99985400del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_007129.5" sequenceAccession="NM_007129" sequenceVersion="5" change="c.1317del" MANESelect="true">
            <Expression>NM_007129.5:c.1317del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_009060.2" sequenceAccession="NP_009060" sequenceVersion="2" change="p.Leu440fs">
            <Expression>NP_009060.2:p.Leu440fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007085.3" sequenceAccession="NG_007085" sequenceVersion="3" change="g.8645del">
            <Expression>NG_007085.3:g.8645del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.10" sequenceAccession="NC_000013" sequenceVersion="10" change="g.100637654del" Assembly="GRCh37">
            <Expression>NC_000013.10:g.100637654del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_053074.1" sequenceAccession="NG_053074" sequenceVersion="1" change="g.52del">
            <Expression>NG_053074.1:g.52del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1157" sequenceAccession="LRG_1157">
            <Expression>LRG_1157:g.8645del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1157t1" sequenceAccession="LRG_1157t1">
            <Expression>LRG_1157t1:c.1317del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1157p1" sequenceAccession="LRG_1157p1" change="p.Leu440fs">
            <Expression>LRG_1157p1:p.Leu440fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1594292057" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_007129.5(ZIC2):c.1317del (p.Leu440fs) AND Holoprosencephaly 5" Accession="RCV001001046" Version="9">
        <ClassifiedConditionList TraitSetID="1837">
          <ClassifiedCondition DB="MedGen" ID="C1864827">Holoprosencephaly 5</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-04-20" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-04-20" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2020-02-10" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="1837" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2049" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Holoprosencephaly 5</ElementValue>
                <XRef ID="Holoprosencephaly+5/8562" DB="Genetic Alliance" />
                <XRef ID="MONDO:0012322" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HPE5</ElementValue>
                <XRef Type="MIM" ID="609637" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">Holoprosencephaly</Attribute>
                <XRef ID="NBK1530" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301702</ID>
                <ID Source="BookShelf">NBK1530</ID>
              </Citation>
              <XRef ID="2162" DB="Orphanet" />
              <XRef ID="C1864827" DB="MedGen" />
              <XRef ID="MONDO:0012322" DB="MONDO" />
              <XRef Type="MIM" ID="609637" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2282570" SubmissionDate="2019-08-05" DateLastUpdated="2020-02-10" DateCreated="2020-02-10">
        <ClinVarSubmissionID localKey="2232150|OMIM:609637" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV001158166" DateUpdated="2020-02-10" DateCreated="2020-02-10" Type="SCV" Version="1" SubmitterName="ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories" OrgID="25969" OrganizationCategory="laboratory" OrgAbbreviation="ARUP" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-02-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The ZIC2 c.1317delG; p.Leu440fs variant, to our knowledge, is not reported in the medical literature or gene specific databases. This variant is also absent from general population databases (Exome Variant Server, Genome Aggregation Database), indicating it is not a common polymorphism. This variant causes a frameshift by deleting a single nucleotide, so it is predicted to result in a truncated protein or mRNA subject to nonsense-mediated decay. Additionally, ZIC2 loss-of-function is a known mechanism of disease, and truncating variants downstream of the p.Leu440fs variant have been reported in individuals with holoprosencephaly (Roessler 2009). Based on available information, this variant is considered to be pathogenic. References: Roessler E et al. The full spectrum of holoprosencephaly-associated mutations within the ZIC2 gene in humans predicts loss-of-function as the predominant disease mechanism. Hum Mutat. 2009 Apr;30(4):E541-54.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ARUP Molecular Germline Variant Investigation Process</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/w2yp3qyt/arup_molecular_germline_variant_investigation_process.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000013.10:g.100637654delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="609637" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>Aug 2019 ARUP</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8294139" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2024-02-20">
        <ClinVarSubmissionID localKey="18656846|MedGen:C1864827" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004506275" DateUpdated="2024-02-20" DateCreated="2024-02-20" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 811286). This frameshift has been observed in individual(s) with holoprosencephaly (Invitae). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change results in a frameshift in the ZIC2 gene (p.Leu440Trpfs*115). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 93 amino acid(s) of the ZIC2 protein and extend the protein by 21 additional amino acid residues.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ZIC2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000013.10:g.100637651del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1864827" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8294139" TraitType="Disease" MappingType="XRef" MappingValue="C1864827" MappingRef="MedGen">
        <MedGen CUI="C1864827" Name="Holoprosencephaly 5" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2282570" TraitType="Disease" MappingType="XRef" MappingValue="609637" MappingRef="OMIM">
        <MedGen CUI="C1864827" Name="Holoprosencephaly 5" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

